Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 363 | -82.34%3.93K | -71.93%22.28K | 79.36K | ||||||
| Other cash income from operating activities | --363 | ---- | ---- | ---- | ---- | -82.34%3.93K | -71.93%22.28K | --79.36K | ---- | ---- |
| Cash paid | -1.86%-1.44M | -25.60%-1.41M | 8.48%-1.12M | 28.08%-1.23M | -106.82%-1.71M | 30.97%-825.32K | -44.05%-1.2M | -5.92%-829.94K | 3.48%-783.56K | 34.96%-811.84K |
| Payments to suppliers for goods and services | -1.86%-1.44M | -25.60%-1.41M | 8.48%-1.12M | 28.08%-1.23M | -106.82%-1.71M | 30.97%-825.32K | -44.05%-1.2M | -5.92%-829.94K | 3.48%-783.56K | 34.96%-811.84K |
| Direct interest received | -69.92%30.55K | 142.01%101.55K | 551.99%41.96K | -46.40%6.44K | -89.03%12.01K | 1,300.79%109.46K | -26.12%7.81K | -7.10%10.58K | 212.69%11.39K | -86.70%3.64K |
| Operating cash flow | -7.40%-1.41M | -21.09%-1.31M | 11.43%-1.08M | 27.95%-1.22M | -138.08%-1.69M | 38.91%-711.93K | -57.50%-1.17M | 4.17%-740K | 4.46%-772.18K | 33.80%-808.2K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -197.86%-2.9M | 22.77%-975.08K | -31.12%-1.26M | -179.70%-962.89K | -112.15%-344.26K | 389.27%2.83M | -44.86%-979.72K | -179.83%-676.33K | 431.88%847.26K | 70.62%-255.29K |
| Capital expenditure reported | -199.18%-2.88M | 23.73%-962.89K | -33.33%-1.26M | -197.16%-946.94K | -108.26%-318.66K | 2.83%-153.01K | 18.00%-157.46K | 36.60%-192.02K | -129.53%-302.86K | 84.96%-131.95K |
| Net PPE purchase and sale | 63.72%-4.12K | ---11.35K | ---- | 37.66%-15.96K | -753.55%-25.6K | ---3K | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---20.41K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --227.94K | ---- |
| Net investment purchase and sale | 200.00%838 | ---838 | ---- | ---- | ---- | ---- | -69.78%-822.25K | -623.01%-484.31K | 175.07%92.6K | ---123.35K |
| Net other investing changes | ---- | --571.35K | ---- | ---- | ---- | --2.99M | ---- | ---- | --829.58K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -197.86%-2.9M | 22.77%-975.08K | -31.12%-1.26M | -179.70%-962.89K | -112.15%-344.26K | 389.27%2.83M | -44.86%-979.72K | -179.83%-676.33K | 431.88%847.26K | 70.62%-255.29K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 87.53%3.47M | 1.85M | -100.17%-9.67K | 29,325.15%5.62M | -101.08%-19.23K | 145.53%1.79M | -51.36%728K | 102.54%1.5M | 291.15%738.94K | |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -131.12%-109.76K | --352.67K |
| Net common stock issuance | 87.53%3.47M | --1.85M | ---- | -100.17%-9.67K | 29,325.15%5.62M | -101.08%-19.23K | 145.53%1.79M | -54.68%728K | 315.89%1.61M | 104.47%386.26K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 87.53%3.47M | --1.85M | ---- | -100.17%-9.67K | 29,325.15%5.62M | -101.08%-19.23K | 145.53%1.79M | -51.36%728K | 102.54%1.5M | 291.15%738.94K |
| Net cash flow | ||||||||||
| Beginning cash position | -23.80%1.4M | -56.04%1.84M | -34.43%4.18M | 128.07%6.38M | 303.11%2.8M | -34.16%693.51K | -38.91%1.05M | 765.49%1.72M | -62.53%199.23K | -78.00%531.75K |
| Current changes in cash | -93.58%-845.07K | 81.38%-436.54K | -6.85%-2.34M | -161.28%-2.19M | 70.24%3.58M | 687.85%2.1M | 48.03%-357.72K | -143.79%-688.33K | 584.28%1.57M | 82.93%-324.56K |
| Effect of exchange rate changes | 262.88%1.52K | -169.55%-932 | 183.70%1.34K | -598.75%-1.6K | 143.09%321 | 65.02%-745 | -112.27%-2.13K | 137.20%17.36K | -486.37%-46.67K | -148.84%-7.96K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | --1.93K | ---- | ---- | ---- | ---- |
| End cash Position | -60.24%556.73K | -23.80%1.4M | -56.04%1.84M | -34.43%4.18M | 127.91%6.38M | 303.39%2.8M | -34.16%693.51K | -38.91%1.05M | 765.49%1.72M | -62.53%199.23K |
| Free cash from | -87.90%-4.29M | 2.57%-2.28M | -7.33%-2.34M | -7.10%-2.18M | -134.95%-2.04M | 34.39%-867.94K | -41.94%-1.32M | 13.30%-932.02K | -14.35%-1.08M | 55.19%-940.15K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |